Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 4
2015 5
2016 3
2017 2
2018 4
2019 5
2020 2
2021 13
2022 6
2023 11
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Target product profiles: tests for tuberculosis treatment monitoring and optimization.
Gupta-Wright A, den Boon S, MacLean EL, Cirillo D, Cobelens F, Gillespie SH, Kohli M, Ruhwald M, Savic R, Brigden G, Gidado M, Goletti D, Hanna D, Hasan R, Hewison C, Koura KG, Lienhardt C, Lungu P, McHugh TD, McKenna L, Scott C, Scriba T, Sekaggya-Wiltshire C, Kasaeva T, Zignol M, Denkinger CM, Falzon D. Gupta-Wright A, et al. Among authors: savic r. Bull World Health Organ. 2023 Nov 1;101(11):730-737. doi: 10.2471/BLT.23.290901. Epub 2023 Oct 4. Bull World Health Organ. 2023. PMID: 37961060 Free PMC article.
Identifying patients with multidrug-resistant tuberculosis who may benefit from shorter durations of treatment.
Winters N, Schnitzer ME, Campbell JR, Ripley S, Winston C, Savic R, Ahmad N, Bisson G, Dheda K, Esmail A, Gegia M, Monedero I, Dalcolmo MP, Rodrigues D, Singla R, Yim JJ, Menzies D. Winters N, et al. Among authors: savic r. PLoS One. 2023 Oct 5;18(10):e0292106. doi: 10.1371/journal.pone.0292106. eCollection 2023. PLoS One. 2023. PMID: 37797071 Free PMC article.
Combining pharmacometric models with predictive and prognostic biomarkers for precision therapy in Crohn's disease: A case study of brazikumab.
Zhang N, Chan ML, Li J, Brohawn PZ, Sun B, Vainshtein I, Roskos LK, Faggioni R, Savic RM. Zhang N, et al. Among authors: savic rm. CPT Pharmacometrics Syst Pharmacol. 2023 Dec;12(12):1945-1959. doi: 10.1002/psp4.13044. Epub 2023 Oct 6. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 37691451 Free PMC article. Clinical Trial.
QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric Studies.
Ali AM, Radtke KK, Hesseling AC, Winckler J, Schaaf HS, Draper HR, Solans BP, van der Laan L, Hughes J, Fourie B, Nielsen J, Garcia-Prats AJ, Savic RM. Ali AM, et al. Among authors: savic rm. Antimicrob Agents Chemother. 2023 Jul 18;67(7):e0144822. doi: 10.1128/aac.01448-22. Epub 2023 Jun 26. Antimicrob Agents Chemother. 2023. PMID: 37358463 Free PMC article.
57 results